Financials Clover Corporation Limited

Equities

Market Closed - Australian S.E. Other stock markets 11:40:44 26/04/2024 am IST			5-day change	1st Jan Change
0.52 ^AUD	-0.95%		-0.95%	-36.97%

20/03	Clover Swings to Loss in H1 FY24; Shares Down 16%	MT
19/03	Clover Corporation Limited Reports Earnings Results for the Half Year Ended January 31, 2024	CI

Fiscal Period: July	2019	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	383.2	369.2	291.3	178.9	182	86.84	-	-
Enterprise Value (EV) ¹	388.4	374.6	296.4	180.9	184.3	92.82	89.32	87.14
P/E ratio	38.2 x	29.8 x	48.5 x	25.1 x	29.3 x	144 x	24.9 x	17.8 x
Yield	1.02%	1.13%	0.57%	1.4%	1.38%	-	1.61%	2.25%
Capitalization / Revenue	5 x	4.18 x	4.81 x	2.53 x	2.28 x	1.34 x	1.15 x	1.03 x
EV / Revenue	5.07 x	4.24 x	4.9 x	2.56 x	2.31 x	1.44 x	1.19 x	1.03 x
EV / EBITDA	27 x	19.7 x	31.3 x	15.5 x	17.6 x	25.5 x	13 x	9.91 x
EV / FCF	3,73,39,890 x	-	-	-	-	-	-	-
FCF Yield	0%	-	-	-	-	-	-	-
Price to Book	8.56 x	-	4.98 x	2.84 x	2.71 x	1.3 x	1.25 x	1.19 x
Nbr of stocks (in thousands)	1,65,182	1,66,310	1,66,439	1,66,439	1,66,999	1,66,999	-	-
Reference price ²	2.320	2.220	1.750	1.075	1.090	0.5200	0.5200	0.5200
Announcement Date	19/09/19	17/09/20	20/09/21	14/09/22	25/09/23	-	-	-

¹AUD in Million²AUD

Estimates

Fiscal Period: July	2019	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	76.68	88.28	60.5	70.66	79.88	64.64	75.37	84.23
EBITDA ¹	14.37	19	9.463	11.66	10.5	3.639	6.857	8.796
EBIT ¹	13.96	18.32	8.756	10.3	10.26	2.536	5.699	7.618
Operating Margin	18.21%	20.75%	14.47%	14.57%	12.84%	3.92%	7.56%	9.04%
Earnings before Tax (EBT) ¹	13.96	17.66	8.175	9.84	8.361	1.077	4.773	6.692
Net income ¹	10.1	12.49	6.004	7.133	6.205	0.6055	3.484	4.885
Net margin	13.17%	14.14%	9.92%	10.09%	7.77%	0.94%	4.62%	5.8%
EPS ²	0.0607	0.0745	0.0361	0.0429	0.0372	0.003600	0.0209	0.0292
Free Cash Flow	10.4	-	-	-	-	-	-	-
FCF margin	13.57%	-	-	-	-	-	-	-
FCF Conversion (EBITDA)	72.37%	-	-	-	-	-	-	-
FCF Conversion (Net income)	102.98%	-	-	-	-	-	-	-
Dividend per Share ²	0.0238	0.0250	0.0100	0.0150	0.0150	-	0.008350	0.0117
Announcement Date	19/09/19	17/09/20	20/09/21	14/09/22	25/09/23	-	-	-

¹AUD in Million²AUD

Estimates

Fiscal Period: Juli	2019	2020	2021	2022	2023	2024	2025	2026
Net Debt ¹	5.19	5.38	5.1	1.97	2.28	5.98	2.48	0.3
Net Cash position ¹	-	-	-	-	-	-	-	-
Leverage (Debt/EBITDA)	0.361 x	0.2829 x	0.5384 x	0.1687 x	0.2167 x	1.643 x	0.3621 x	0.0343 x
Free Cash Flow	10.4	-	-	-	-	-	-	-
ROE (net income / shareholders' equity)	24.3%	24.3%	10.4%	11.7%	9.53%	0.91%	5.12%	6.86%
ROA (Net income/ Total Assets)	15.9%	16%	7.49%	-	-	-	-	-
Assets ¹	63.4	78.12	80.11	-	-	-	-	-
Book Value Per Share ²	0.2700	-	0.3500	0.3800	0.4000	0.4000	0.4200	0.4400
Cash Flow per Share	0.0300	0.0400	0.0500	-	-	-	-	-
Capex ¹	0.11	0.56	1.83	1.6	-	1.45	1.3	1.36
Capex / Sales	0.14%	0.63%	3.03%	2.26%	-	2.24%	1.73%	1.61%
Announcement Date	19/09/19	17/09/20	20/09/21	14/09/22	25/09/23	-	-	-

¹AUD in Million²AUD

Estimates

Trading Rating

Investor Rating

ESG Refinitiv

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

0.52 AUD

Average target price

0.6 AUD

Spread / Average Target

+15.38%

	1st Jan change	Capi.
CLOVER CORPORATION LIMITED	-36.97%	56.63M
ZHEJIANG NHU COMPANY LTD.	+8.20%	7.78B
BELLRING BRANDS, INC.	+0.34%	7.38B
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	+10.20%	6.52B
BYHEALTH CO., LTD	-8.10%	3.67B
XIAMEN KINGDOMWAY GROUP COMPANY	-14.57%	1.17B
SIRIO PHARMA CO., LTD.	+8.34%	934M
HERBALIFE LTD.	-42.27%	879M
USANA HEALTH SCIENCES, INC.	-18.90%	836M
JAMIESON WELLNESS INC.	-16.45%	802M